Advertisement
News
Advertisement

Research Evaluating Effectiveness of Behavioral Counseling and Varenicline for Smoking Cessation Featured in the American Journal of Preventive Medicine

Tue, 05/18/2010 - 12:36pm
Bio-Medicine.Org

MENLO PARK, Calif., May 18 /PRNewswire/ -- A recently completed randomized trial compared three ways to deliver a behavioral smoking cessation program using varenicline (Chantix®): by phone, web, or both.  Although phone counseling had greater treatment advantage for early cessation and appeared to increase medication adherence, no differences in abstinence outcomes were seen at six months. The findings suggest the three programs are all effective treatment options when combined with varenicline.  Nonprofit scientific research institute SRI International, Group Health Research Institute, and Free & Clear, Inc. conducted the trial, which was published in the May 2010 American Journal of Preventive Medicine.

Proactive telephone behavioral counseling (PTC) and web-based services are popular tools for smoking cessation. Although both PTC and web-based services are known to be effective, previous studies have not examined whether a combination of these services results in better outcomes than one method alone.  The trial aimed to determine the relative effectiveness of a widely used smoking cessation program (Free & Clear Quit For Life® Program) that was delivered in three ways: standard PTC, web-based delivery, and a program that combined the two.

The trial was one of the first "real-

'/>"/>

SOURCE

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading